Skip to article frontmatterSkip to article content
Site not loading correctly?

This may be due to an incorrect BASE_URL configuration. See the MyST Documentation for reference.

Seven FUTURE-AI recommendations apply across all six principles Lekadir et al. (2025).

G1: Engage interdisciplinary stakeholders throughout the lifecycle

Research ++, deployable ++. Involve healthcare professionals, patients, ethicists, data managers and legal experts from design to deployment, through working groups, advisory boards, interviews, co-creation meetings or surveys.

→ See: Stakeholder engagement

G2: Protect data privacy and security

Research ++, deployable ++. Use privacy-enhancing techniques, carry out a data protection impact assessment (DPIA, the risk assessment the GDPR European Parliament and Council (2016) requires before high-risk processing such as AI on health data), control access after deployment and protect the tool against attacks. In Dutch healthcare, NEN 7510 is the standard for information security.

→ See: Privacy and security

G3: Address the risks you identified

Research ++, deployable ++. Turn the risks found during design into measures in your modelling plan, such as data augmentation for robustness, transfer learning for new settings, or resampling to correct bias between groups.

→ See: Risk management planning, Addressing AI risks

G4: Define an adequate evaluation plan

Research ++, deployable ++. Before you evaluate, fix the test data (kept strictly apart from the training data), the metrics, and a reference to compare against, such as current practice.

→ See: Evaluation planning

G5: Identify and comply with regulatory requirements

Research +, deployable ++. Identify early which rules apply, because they shape design choices. In the EU these include the GDPR, the MDR European Parliament and Council (2017) or IVDR European Parliament and Council (2017) and the EU AI Act European Parliament and Council (2024). The paper says the AI Act classes all healthcare AI as high-risk; the Act itself is narrower (see the FUTURE-AI overview).

→ See: Legal and regulatory considerations, Regulatory compliance

G6: Investigate and address application-specific ethical issues

Research +, deployable ++. Beyond privacy, transparency, equity and autonomy, ask developers, clinicians and ethicists which ethical issues your particular application raises.

→ See: Ethical review and approval

G7: Investigate and address social and societal issues

Research +, deployable +. Consider effects on working conditions, professional skills (including their loss), relations between patients and professionals, and the tool’s carbon footprint.

→ See: Social and societal impact

References
  1. Lekadir, K., Frangi, A. F., Porras, A. R., & others. (2025). FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare. BMJ, 388, e081554. 10.1136/bmj-2024-081554
  2. European Parliament and Council. (2016). Regulation (EU) 2016/679 – General Data Protection Regulation. Official Journal of the European Union.
  3. European Parliament and Council. (2017). Regulation (EU) 2017/745 on medical devices (MDR) [Techreport]. Official Journal of the European Union.
  4. European Parliament and Council. (2017). Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) [Techreport]. Official Journal of the European Union.
  5. European Parliament and Council. (2024). Regulation (EU) 2024/1689 of the European Parliament and of the Council on artificial intelligence. Official Journal of the European Union.